ESR1 and breast carcinoma: In this prospective observational study, we performed DXA scans, MR FACT sequence, and serological tests to clarify changes in spinal marrow PDFF, BMD at the femoral neck, total hip and lumbar spine, and bone turnover biomarker levels in postmenopausal women with estrogen receptor-positive early-stage breast cancer receiving AIs.